Hyperhomocysteinemia is associated with lower performance on memory tasks in post-menopausal women

Dementia and Geriatric Cognitive Disorders

Volumn 20, Issue 2-3, 2005, Pages 57-62

  Clark, Margaret S ^a   Guthrie, Janet R ^a   Dennerstein, Lorraine ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Alzheimer's disease; Hyperhomocysteinemia; Mild cognitive impairment; Vitamin B

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; VITAMIN B GROUP;

ADULT; AGE DISTRIBUTION; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; DISEASE ASSOCIATION; FEMALE; HORMONAL THERAPY; HUMAN; HYPERCHOLESTEROLEMIA; LEARNING; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; SMOKING; TASK PERFORMANCE; VERBAL MEMORY; VITAMIN SUPPLEMENTATION; WORKING MEMORY;

AGED; COGNITION; COHORT STUDIES; DRUG THERAPY; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; LONGITUDINAL STUDIES; MEMORY; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSTMENOPAUSE; PROSPECTIVE STUDIES; PSYCHOMOTOR PERFORMANCE;

EID: 23944436150     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085856     Document Type: Article

References (45)

1. 12 deficiency in primary degenerative dementia. Dementia 1990;1:272-277.
2. 12 and serum total homocysteine levels in confirmed Alzheimer Disease. Arch Neurol 1998;55:1440-1455.
3. Seshadri S, Beiser A, Selhub J, et al: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483.
4. McCaddon A, Davies G, Hudson P, Tandy S, Cattell H: Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry. 1998;13:235-239.
5. Religa D, Styczynska M, Peplonska B, et al: Homocysteine, apolipoprotein E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment. Dem Geriatr Cogn Disord 2003;16:64-70.
6. Petersen RC, Doody R, Kurz A, et al: Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992.
7. Selhub J, Bagley LC, Miller J, Rosenberg IH: B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr. 2000;71:6148-6205.
8. Clarke R, Harrison G, Richards S, Vital Trial Collaborative G: Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J Intern Med 2003;254:67-75.
9. 6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment. Dement Geriatr Cogn Disord 2003;16:145-150.
10. 12 for cognition and dementia (Systematic review). Cochrane Dementia and Cognitive Improvement Group. Cochrane Database of Systematic Reviews 2004;3:3.
11. 6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 1996;63:306-314.
12. Lehmann M, Gottfries CG, Regland B: Identification of cognitive impairment in the elderly: Homocysteine is an early marker. Dement Geriatr Cogn Disord. 1999;10:12-20.
13. Budge MM, de Jager C, Hogervorst E, Smith AD, Oxford Project to Investigate Memory and Ageing (OPTIMA): Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people. J Am Geriatr Soc 2002;50:2014-2018.
14. Morris MS, Jacques PF, Rosenberg IH, Selhub J, National Health, Nutrition Examination Survey: Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2001;73:927-933.
15. McCaddon A, Hudson P, Davies G, Hughes A, Williams JH, Wilkinson C: Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001;12:309-313.
16. Duthie SJ, Whalley LJ, Collins AR, Leaper S, Berger K, Deary IJ: Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr 2002;75:908-913.
17. Prins ND, Den Heijer T, Hofman A, et al: Homocysteine and cognitive function in the elderly: The Rotterdam Scan Study. Neurology 2002;59:1375-1380.
18. Teunissen CE, Blom AH, Van Boxtel MP, et al: Homocysteine: A marker for cognitive performance? A longitudinal follow-up study. J Nutr Health Aging 2003;7:153-159.
19. Miller JW, Green R, Ramos MI, et al: Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2003;78:441-447.
20. Ravaglia G, Forti P, Maioli F, et al: Homocysteine and cognitive function in healthy elderly community dwellers in Italy. Am J Clin Nutr 2003;77:668-673.
21. Budge M, Johnston C, Hogervorst E, et al: Plasma total homocysteine and cognitive performance in a volunteer elderly population. Ann N Y Acad Sci 2000;903:407-410.
22. Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MM: Total homocysteine and cognitive decline in a community-based sample of elderly subjects: The Rotterdam Study. Am J Epidemiol 1999;150:283-289.
23. Ravaglia G, Forti P, Maioli F, et al: Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment. Mech Ageing Dev 2000;121:251-261.
24. Ravaglia G, Forti P, Maioli F, et al: Blood homocysteine and vitamin B levels are not associated with cognitive skills in healthy normally ageing subjects. J Nutr Health Aging 2000;4:218-222.
25. La Rue A, Koehler KM, et al: Nutritional status and cognitive functioning in a normally aging sample: A 6-y reassessment. Am J Clin Nutr 1997;65:20-29.
26. Petersen R, Smith G, Waring S, Ivnik R, Tangalos E, Kokmen E: Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56:303-308.
27. Davison S, Davis SR: New markers for cardiovascular disease risk in women: Impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab 2003;88:2470-2478.
28. Dennerstein L, Smith A, Morse C, et al: Menopausal symptomatology: the experience of Australian women. Med J Aust 1993;159:232-236.
29. Burger H, Dudley E, Hopper J, et al: The endocrinology of the menopausal transition: A cross-sectional study of a population-based sample. J Clin Endocrinol Metab 1995;80:3537-3545.
30. Andresen E, Malmgren J: Screening for depression in well older adults: Evaluation of a short form of the CES-D. Am J Prevent Med 1994;10:77-84.
31. Delis D, Kramer J, Kaplan E, Ober B: CVLT-II adult version. San Antonio, The Psychological Corporation, 2000.
32. Clark M, Dennerstein L, Elkadi S, Guthrie J, Bowden S, Henderson V: Normative verbal and non-verbal memory test scores for Australian women aged 65-67. Aust NZ J Psychiatry 2004;38:532-540.
33. Collie A, Shafiq-Antonacci R, Maruff P, Tyler P, Currie J: Norms and the effects of demographic variables on a neuropsychological battery for use in healthy ageing Australian populations. Aust NZ J Psychiatry 1999;33:568-576.
34. The Psychological Corporation: WAIS-III Letter Number Sequencing. Harcourt Brace, San Antonio, 1997.
35. Clark M, Dennerstein L, Elkadi S, Guthrie J, Bowden S, Henderson V: Normative data for tasks of executive cognitive function for Australian born women aged 56-67. Aust Psychologist 2004;39:244-250.
36. Nelson HE, O'Connell A: Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex 1978;14:234-244.
37. Crawford JR, Parker DM: Prediction of WAIS IQ with the National Adult Reading Test: Cross-validation and extension. Br J Clin Psychol 1989;28:267-273.
38. Jacques P, Selhub J, Bostom A, Wilson P, Rosenberg I: The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-1454.
39. Norusis M: SPSS 10 for Windows. SPSS Inc., 2002.
40. Dimitrova K, De Broot K, Myers A, Kim Y: Estrogen and homocysteine. Cardiovasc Res 2002;53:577-588.
41. Perry R, Watson P, Hodges J: The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: Relationship to episodic and semantic memory impairment. Neuropsychologia 2000;38:252-271.
42. Fashbender K, Mielke O, Bertsch T, Nafe B, Forschen S, Hennerici M: Homocysteine in cerebral macropangiography. Lancet 1999;353:1586-1587.
43. Lipton S, Kim W, Choi Y: Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Nat Acad Sci 1997;94:5923-5928.
44. Flicker L, Martins RN, Thomas J, et al: Homocysteine, Alzheimer genes and proteins, and measures of cognition and depression in older men. J Alzheimers Dis 2004;6:329-336.
45. Pak KJ, Chan SL, Mattson MP: Homocysteine and folate deficiency sensitize oligodendrocytes to the cell death-promoting effects of a presenilin-1 mutation and amyloid beta-peptide. Neuromolecular Med 2003;3:119-128.